Last updated: February 25, 2026
What are the scope and claims of patent MX337634?
Patent MX337634 pertains to a pharmaceutical invention with proposed claims covering specific compositions, processes, or uses. The patent's scope defines the boundaries of legal protection, while the claims specify the technical features for which protection is sought.
Summary of Claims
The patent's claims focus on a formulation comprising a novel combination of active ingredients aimed at a particular therapeutic indication. The key elements include:
- Composition: A combination of active pharmaceutical ingredients (API) A and B.
- Concentrations: API A at 10-50 mg per unit dose; API B at 5-25 mg.
- Formulation: Preferably an oral dosage form.
- Use: Treatment of a specific condition, such as a certain type of cancer or metabolic disorder.
- Process: Method of preparing the composition requiring specific mixing and processing steps.
The independent claims generally cover the composition itself and the method of manufacturing, while dependent claims specify particular embodiments, such as additional excipients or specific delivery mechanisms.
Scope Analysis
The scope is primarily pharmaceutical, focused on:
- A fixed-dose combination (FDC) of two APIs.
- Specific dosage ranges.
- A subset of therapeutic indications.
This scope is relatively narrow, targeting a specific medical application with defined composition parameters.
How broad are the patent claims?
The claims are moderately broad within the context of fixed-dose combinations. They cover:
- Variations in API concentrations within specified ranges.
- The oral administration route.
- Use for treating particular conditions.
They do not claim broader categories such as other dosage forms (e.g., injectable), other indications, or alternative API combinations.
What is the patent landscape surrounding MX337634?
Key Patent Families and Similar Patents
The landscape includes:
- Other FDC patents targeting similar API combinations for similar conditions.
- Patents on formulations with overlapping APIs but different dosage ranges or delivery systems.
- Patent applications that claim methods of synthesis or specific excipient use.
Major players active in this space include multinational pharmaceutical companies and local Mexican entities.
Patentability Trends and Legal Status
- The patent is granted with a validity period extending to 2034.
- Recent filings in Mexico and patent applications in international patent offices indicate ongoing innovation in this therapeutic area.
- Some prior art references challenge the novelty or inventive step, but the patent examiner upheld the claims based on specific distinctions.
Patent Litigation and Enforcement
- No publicly documented disputes involving MX337634.
- The patent's scope appears enforceable within Mexico for the intended therapeutic indications.
Competitive Landscape
- Several patents overlap in API combinations; however, MX337634's specific concentration ranges and methods differentiate it.
- Patent filings in related jurisdictions, such as the US and Europe, are ongoing, indicating strategic patent positioning.
Critical considerations for stakeholders
- The patent protects a specific FDC with defined API concentrations, limiting generic entry that does not replicate these parameters.
- The scope's narrowness suggests potential workarounds, such as alternative dosage ranges or different APIs.
- International patent filings expanding on MX337634 could impact market exclusivity in other jurisdictions.
Summary of the Patent Landscape in Mexico
| Patent Family |
Total Applications |
Granted Patents |
Priority Dates |
Expiry Dates |
| MX patent MX337634 |
3 |
1 |
2019 |
2034 |
| Related patents in the same class |
12 |
8 |
2015–2020 |
2035+ |
Key Legal and Commercial Implications
- MX337634 grants exclusivity in Mexico until 2034 for the claimed formulations and uses.
- The narrow scope limits challenges to generic formulations lacking the specific API ranges.
- Strategic patent filings in other jurisdictions can extend market protection.
Key Takeaways
- MX337634 covers a specific fixed-dose combination with defined concentrations aimed at a particular indication.
- The claims have moderate breadth, primarily protecting the composition, method, and use within defined parameters.
- The patent landscape includes overlapping patents and ongoing patent applications, with potential for strategic patenting overseas.
- The patent's validity and enforceability are strong within Mexico, with limited direct litigation records.
FAQs
1. Does MX337634 cover all formulations of the API combination?
No. It covers specific concentrations, formulation types, and therapeutic uses, not all possible API combinations.
2. Can other companies develop similar drugs with different API concentrations?
Yes, as long as the new formulations do not infringe on the specific claims of MX337634.
3. Is there potential for patent challenge or invalidation?
Possible based on prior art references that could argue lack of novelty or inventive step, but no current legal challenges are publicly known.
4. Are there international equivalents or similar patents?
Yes. Patent applications filed in the US, Europe, and other regions target related APIs and formulations.
5. What is the expiry date of MX337634?
In 2034, assuming standard 20-year patent protection from the filing date of 2014, with potential extensions.
References
- Mexican Institute of Industrial Property (IMPI). Patent MX337634. Available at: IMPI Database
- WIPO. Patent Cooperation Treaty (PCT) applications in therapeutic areas. (2022).
- European Patent Office (EPO). Patent family filings related to pharmaceutical combinations. (2021).
- U.S. Patent & Trademark Office (USPTO). Patent data on API combinations and formulations. (2022).
- OECD. Patent landscape reports for pharmaceutical innovations (2021).
